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Introduction
Ever since joining the European 
Union, Malta has been trying 
extensively to conform to European 
standards as requested by legislation. 
Improvements have been registered 
in several sectors; however the 
research in the management of waste 
pharmaceuticals has so far remained 
lacking.1
Aims 
This report draws findings of 
a scientific study that has been 
undertaken by the authors and aims to 
provide a programme and a guidance 
proposal plan for the management 
and disposal of pharmaceutical waste 
produced by consumers. The process 
of designing and implementing a 
successful pharmaceutical waste 
management program, being highly 
interdisciplinary, has to be acceptable 
for pharmacies, competent authorities 
and consumers alike.2
Educational programs
Educational programs should be 
set up to educate consumers on the 
threats resulting from the irresponsible 
disposal of pharmaceutical waste. The 
proposed programs should educate 
users on new, well thought-out and 
science-founded procedures.3 The 
benefits should be highlighted to 
encourage people to make an effort to 
abide by these guidelines. 
Such educational programs include:
• Promoting the campaign on 
television programs including waste 
management ‘spots’ on TV;
• Advertisements on published media;
• Distribution of leaflets from 
community pharmacies;
• Other advertising materials including 
banners and posters.
Consumers’ pharmaceutical waste
Examples of consumers’ 
pharmaceutical waste include:
• Expired medicines in households;
• Medicines discontinued by 
manufacturers due to a negative 
risk-benefit ratio; 
• Medicines not consumed by 
patients;
• Medicines discontinued because the 
doctor prescribed new medication;
• Medicines of deceased patients.
Since pharmaceutical waste 
production in nursing homes is 
significantly higher than in households, 
this scheme is not applicable. In 
this setting, clinical waste is also 
produced and thus nursing homes 
should contract a private waste 
management company to manage their 
pharmaceutical and clinical waste. 
Hospitals have their in-house waste 
management procedures. 
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Figure 1: Open Pharmaceutical Waste Container
Kontenitur ta’ mediçini g˙ar-rimi
Pilloli, kapsuli, patches u qratas 
immarkati bil-blu biss jistghu 
jintremew f’dan il-kontenitur
Pharmaceutical waste container
Only blue-labelled tablets, capsules, 
patches and sachets can be disposed 
of in this container
TECHNOLOGY IN PRACTICE
The management of pharmaceutical waste is 
increasingly becoming of great 
concern to our society since no 
official program currently exists. 
This study proposes a management 
plan for consumer’s pharmaceutical 
waste in a pharmacy setting in 
Malta. It involves disposing of 
unwanted solid dosage-forms in 
their original packaging in waste 
containers which will be installed in 
front of pharmacies, and returning 
hazardous medicines and other 
dosage-forms directly to the 
pharmacist to reduce hazards from 
mixing incompatible products. 
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Household waste medicines 
are found in various dosage 
forms; the most common being 
tablets, capsules, caplets, syrups, 
suspensions, inhalers, suppositories, 
pessaries, creams, ointments, sprays, 
drops, powder for oral constitution 
and patches.4
Syringes are not included in 
this scheme. Yellow UN approved 
containers should be distributed to 
frequent syringe users from healthcare 
centres. When the yellow bin is full, 
consumers should return the bin 
to the centre and they are given 
an empty one. The bins are then 
collected from the healthcare centres 
by waste carriers. 
Hazardous waste
Section 4(2) of the Waste 
Management Act of 2001 defines 
Hazardous Waste as having certain 
properties which can be harmful to 
human health and the environment. 
“These properties are corrosive, 
explosive, toxic, flammable, oxidizing, 
irritant, harmful, carcinogenic, 
infectious, teratogenic, mutagenic and 
ecotoxic.”5
Medicines may have a range 
of hazardous properties, but only 
those with one of the hazardous 
properties denoted by “H codes” will 
be classified as a hazardous waste.5 
Other medicines are not hazardous 
within the meaning of the legislation, 
but they are hazardous if released in 
the environment. 
Hazardous medicines
The European Waste Catalogue5 
lists wastes from human healthcare in 
Chapter 18. Medicines consisting of 
or containing dangerous substances 
together with cytotoxic and cytostatic 
medicines are considered to be 
hazardous. Hazardous medicines 
include chemotherapeutic agents, 
antivirals, hormones and some 
bioengineered medicines.6 Most of 
the medicines available in community 
pharmacies are fairly inert and pose 
no particular danger to staff or waste 
carriers who collect the waste. 
This is because most medicines 
are individually packed tablets or 
capsules. The packaging provides 
satisfactory protection for anyone 
handling the container.  However if 
the solid formulation is altered by, for 
example, being crushed, they could 
pose a risk. Blister packaging also 
protects against mixing incompatible 
products and they do not pose a risk to 
the environment provided that they are 
incinerated properly. 2
Pharmacies should develop a list 
of hazardous medicines that are found 
in the pharmacy, including medicines 
available from the Pharmacy of Your 
Choice (POYC Scheme) so as to be 
aware of any risks involved during 
collection. 
Table 1 is a short template of a list 
of medicines available in pharmacies 
which are considered to be hazardous, 
that was compiled as part of the 
scientific study undertaken. This list 
should be modified according to 
what is available at each respective 
pharmacy.  cont in issue 4/11
Table 1: Hazardous medicines available in pharmacies (Source: Malta Medicines List) 
This table is only a summary of the full version which is part of the scientific study entitled ‘Waste 
Management in Pharmacy’
Anti-acne preparations 
Active ingredient Trade Name Formulation 
Clindamycin 10mg/ml Dalacin T Topical solution
Isotretinoin 10mg, 20mg Decutan Capsule, Soft
Anti-bacterials for systemic use 
Clavulanic Acid 125mg;                        
Amoxicillin 500mg 
Augmentin-Duo 
500mg/125mg 
Film-Coated Tablet
Cefaclor 500mg Ceclor MR tablets
Antibiotics and chemotherapeutics for dermatological use 
Retampulin Altargo Ointment 
Mupirocin 2% w/w Bactroban Topical ointment
Intestinal anti-inflammatory and anti-infective agents 
Mesalazine 400mg Pentacol Gastro Resistant Tablet 
Sulfasalazine 500mg Salazopyrin Suppositories
Anti-gout preparation 
Allopurinol 100mg Allopurinol Tablet
Colchicine 500mcg Colchicine Tablet
Anti-neoplastic agents 
Methotrexate 2.5mg Methotrexate Film-Coated Tablet
Imatinib 100mg Imatinib Tablets 
Endocrine therapy
Letrozole 2.5mg Femara Tablet
Tamoxifen 20mg Nolvadex D Film-Coated Tablet
Ophtalmologicals 
Tobramycin 3mg/ml Tobrex Eye Drops, Solution
Aciclovir 3% w/w Zovirax Eye Ointment
Sex hormones and modulators of the genital system 
Estradiol 25mcg Vagifem Vaginal Tablet
Ethinylestradiol 0.03mg, 
Drospirenone 3mg
Yasmin Film-Coated Tablet
Thyroid therapy 
Levothyroxine Sodium 100mcg Eltroxin Tablet
Carbimazole 5mg NeoMercazole 5 Tablet
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